Enbrel — Medica
Ankylosing spondylitis
Initial criteria
- age > 18 years
- prescribed by or in consultation with a rheumatologist
Reauthorization criteria
- patient has been established on therapy for at least 6 months
- patient experienced a beneficial clinical response from baseline when assessed by at least one objective measure OR experienced an improvement in at least one symptom such as decreased pain or stiffness or improvement in function or activities of daily living
Approval duration
initial: 6 months; reauth: 1 year